SANDFORD D SMITH Insider Trading
Get free email notifications about insider trading for SANDFORD D SMITH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SANDFORD D SMITH. SANDFORD D SMITH is a Director in ARIAD PHARMACEUTICALS INC ($ARIA) and a Director in QLT INC/BC ($QLTI) and a Director in APRICUS BIOSCIENCES, INC. ($APRI) and a Director in CYTOKINETICS INC ($CYTK) and an Chief Executive Officer in Aegerion Pharmaceuticals, Inc. ($AEGR) and a Director in Aegerion Pharmaceuticals, Inc. ($AEGR) and a Director in Neuralstem, Inc. ($CUR) and a Director in AKCEA THERAPEUTICS, INC. ($AKCA).
Address: C/O ARIAD PHARMACEUTICALS 26 LANDSDOWNE STREET CAMBRIDGE 02139 MA
Companies in which SANDFORD D SMITH is an Insider
Aegerion Pharmaceuticals, Inc.
Trading Symbol: AEGRIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SANDFORD D SMITH: Chief Executive Officer, Director
Holdings: 0 shares
Latest Transaction: Nov 30 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AKCEA THERAPEUTICS, INC.
Trading Symbol: AKCAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SANDFORD D SMITH: Director
Holdings: 0 shares
Latest Transaction: Oct 13 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ARIAD PHARMACEUTICALS INC
Trading Symbol: ARIAIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of SANDFORD D SMITH: Director
Holdings: 66,205 shares
Current Value: $1,576,341
Latest Transaction: Dec 01 2004
$ARIA Market Capitalization: $4.64B
$ARIA Previous Close: $23.81
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CYTOKINETICS INC
Trading Symbol: CYTKIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SANDFORD D SMITH: Director
Holdings: 5,920 shares
Current Value: $69,264
Latest Transaction: May 13 2021
$CYTK Market Capitalization: $461.88M
$CYTK Previous Close: $11.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NOVELION THERAPEUTICS INC.
Trading Symbol: NVLNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SANDFORD D SMITH: Director
Holdings: 1,048 shares
Latest Transaction: Jan 31 2017
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PALISADE BIO, INC.
Trading Symbol: SNCAIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of SANDFORD D SMITH: Director
Holdings: 219,916 shares
Current Value: $664,146
Latest Transaction: Jul 03 2019
$SNCA Market Capitalization: $28.01M
$SNCA Previous Close: $3.02
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SEELOS THERAPEUTICS, INC.
Trading Symbol: SEELIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SANDFORD D SMITH: Director
Holdings: 16,160 shares
Current Value: $42,501
Latest Transaction: Jan 08 2018
$SEEL Market Capitalization: $20.96M
$SEEL Previous Close: $2.63
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of SANDFORD D SMITH
Sentiment: All, AEGR, AKCA, ARIA, CYTK, NVLN, SNCA, SEEL
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 13 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | A | 24.32 | 10,000 | 243,200 | 10,000 | |
May 13 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Grant | A | 0.00 | 5,000 | 0 | 5,920 | 920 to 5.9 K (+543.48 %) |
Apr 27 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 10.68 | 5,000 | 53,400 | 15,000 | |
Apr 27 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 10.55 | 4,739 | 49,996 | 0 | |
Apr 27 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 28.00 | 5,000 | 140,000 | 920 | 5.9 K to 920 (-84.46 %) |
Apr 27 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 10.68 | 5,000 | 53,400 | 5,920 | 920 to 5.9 K (+543.48 %) |
Apr 27 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 27.50 | 4,739 | 130,323 | 920 | 5.7 K to 920 (-83.74 %) |